Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.29
P/E—
Fwd P/E11.12
PEG0.22
52W— – —
RSI—
Target$116.04 (+22.6%)
Beta0.58
Div2.79%
Loading chart…
RSI ()
Loading patterns…
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 43
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
7Bullish
4Bearish
0Neutral
Key Signals 1
▲ Double Bottom
Major reversal
2026-09-01 · $97.51
Two lows ~$92.68 — bullish reversal confirmed
Learn more →
Momentum Signals 10
▲ Bull Flag
▲ MACD Bullish Crossover
▲ Bull Flag
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
STRONG BUY
BuyHoldSell
Price Target Range
$116.04
+22.6% upside
Low $103
—
High $148
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
13.65%Last 12 Months
Operating Margin
3.86%Last 12 Months
Return on Equity
6.21%Last 12 Months
Revenue Growth
7.10%Year over Year
Free Cash Flow
8.08BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
95.50Most Recent Quarter
Current Ratio
0.87Most Recent Quarter
Cash
13.96BMost Recent Quarter
Total Debt
76.31BMost Recent Quarter
Net Debt
—Most Recent Quarter
How CVS Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 121.07B |
| Enterprise Value | 183.61B |
| Trailing P/E | 25.11 |
| Forward P/E | 11.12 |
| PEG Ratio (5yr) | 0.22 |
| Price/Sales (ttm) | 0.29 |
| Price/Book (mrq) | 1.52 |
| EV/Revenue | 0.45 |
| EV/EBITDA | 11.01 |
Share Statistics
| Avg Vol (3m) | 7.55M |
| Shares Outstanding | 1.28B |
| Float | 1.28B |
| % Held by Insiders | 0.06% |
| % Held by Institutions | 90.82% |
| Short Ratio | 2.32 |
| Short % of Float | 1.43% |
Profitability
| Gross Margin | 13.65% |
| Operating Margin (ttm) | 3.86% |
| Profit Margin | 1.18% |
| Return on Assets (ttm) | 2.97% |
| Return on Equity (ttm) | 6.21% |
Income Statement
| Revenue (ttm) | 412.64B |
| Revenue Growth (yoy) | 7.10% |
| Gross Profit (ttm) | 56.31B |
| EBITDA | 16.68B |
| Net Income (ttm) | 4.89B |
| Diluted EPS (ttm) | 3.77 |
| EPS Growth (yoy) | 188.80% |
Balance Sheet
| Total Cash (mrq) | 13.96B |
| Total Debt (mrq) | 76.31B |
| Debt / Equity (mrq) | 95.50 |
| Current Ratio (mrq) | 0.87 |
| Book Value / Share | 62.37 |
| Operating CF (ttm) | 14.78B |
| Free Cash Flow (ttm) | 8.08B |
Trading & Dividends
| Beta (5Y) | 0.58 |
| 50-Day MA | 100.30 |
| 200-Day MA | 86.83 |
| Fwd Dividend Yield | 2.79% |
| Payout Ratio | 70.18% |
Income
Dividend Yield
2.79%Last 12 Months
Annual Rate
2.66Forward
Payout Ratio
70.18%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 70.18%
Monthly Dividends
Ownership Breakdown
Institutional 90.82%
Insider 0.06%
Public 9.1%
Short Interest
1.43% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in CVS in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|